»Ê¼Ò»ªÈË

These fellowships allow qualified candidates in the UK and Ireland to undertake clinical research, leading towards a PhD, MD or equivalent. Recipients of this fellowship should seek to improve clinical outcomes for people with/at risk of lung cancer.

Muscular Dystrophy UK will fund stipends (up to UKRI minimum rates), university fees, and consumables (up to £10,000 per year).

Muscular Dystrophy UK welcome applications for proof-of-principle grants and project grants. Applications can be made by both early-career researchers and existing principal investigators.

Data Discovery Awards provide support for research projects designed to increase understanding of MS risk factors. It is hoped these awards will provide a more combined approach to assessing someone’s risk of developing MS and will ultimately help to develop new preventative strategies.

Early Career Fellowships aim to attract and retain talented postdoctoral researchers who want to build a successful career in MS research. These grants provide a staged career structure and the opportunity for you to progress towards higher-level appointments.

These Catalyst Awards provide support for short-term, small-scale pilot or proof-of-concept studies, as well as ‘high-risk, high-reward’ innovative research studies.

The Medical Research Foundation are inviting applications from clinicians who have the potential to be the research leaders of the future, to support research that will increase understanding of the disease mechanisms underlying Cancer Pain. Researchers whose work may lead to better understanding of prevention, treatment or management of cancer pain are welcome to apply.

The Medical Research Foundation are inviting applications from clinicians who have the potential to be the research leaders of the future, to support research that will increase understanding of adolescent skin disorders and their treatment. Researchers whose work may lead to better understanding of prevention, treatment or management of these disorders are welcome to apply.

A semi-annual submission for Strategic Research Agreement Letters of Intent that address Breakthrough T1D’s current Research Strategy.

A collaborative grants round to develop and enhance pharmacy-led research and research into nephrotoxicity.